High Katherine A — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
High Katherine A has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.
Profile
Based on the SEC filing context dated 2026-06-09, Katherine A High is listed in connection with CRISPR Therapeutics AG. The filing does not disclose the exact title (e.g., director, officer) or provide a detailed biography. The name resembles Katherine A. High, a notable figure in gene therapy, but there is no public, independently verifiable confirmation that the CRISPR Therapeutics affiliation refers to the same person, or that she holds a current role at the company. Given the potential for name variations and name collisions, the precise identity and role cannot be conclusively determined from the provided SEC context alone.
Role
Director
Notability
45/100
Board memberships
CRISPR Therapeutics AG
Awards & honors
Listed in CRISPR Therapeutics AG SEC filings (as of 2026-06-09) in association with the company
SEC filing context does not provide full biographical details
Based on the SEC filing context dated 2026-06-09, Katherine A High is listed in connection with CRISPR Therapeutics AG. The filing does not disclose the exact title (e.g., director, officer) or provide a detailed biography. The name resembles Katherine A. High, a notable figure in gene therapy, but there is no public, independently verifiable confirmation that the CRISPR Therap…
How many SEC Form 4 filings has High Katherine A submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Where can I see all of High Katherine A's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
